Alpha Tau Medical Ltd. (NASDAQ:DRTSW) Short Interest Down 30.6% in December

Alpha Tau Medical Ltd. (NASDAQ:DRTSW) was the recipient of a large decline in short interest in December. As of December 15th, there was short interest totaling 10,980 shares, a decline of 30.6% from the November 30th total of 15,827 shares. Based on an average daily volume of 9,632 shares, the days-to-cover ratio is currently 1.1 days. Based on an average daily volume of 9,632 shares, the days-to-cover ratio is currently 1.1 days.

Alpha Tau Medical Stock Performance

DRTSW stock opened at $0.36 on Tuesday. Alpha Tau Medical has a one year low of $0.13 and a one year high of $0.50. The firm’s fifty day moving average is $0.33 and its 200 day moving average is $0.30.

About Alpha Tau Medical

Alpha Tau Medical Ltd. is a clinical-stage medical technology company focused on the development of alpha-emitting radiation therapy for the treatment of solid tumor cancers. The company’s proprietary Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) platform leverages the short-range, high-energy alpha particles emitted by radium-224 to penetrate tumor tissues more effectively than conventional external-beam radiation. By implanting thin, needle-like sources directly into a tumor, Alpha DaRT delivers concentrated doses of radiation to malignant cells while sparing surrounding healthy tissue.

The Alpha DaRT technology is designed to enhance local tumor control in a variety of solid tumors, including head and neck, breast, skin, and pancreatic cancers.